{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:32Z","timestamp":1786650032493,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>CD24 is a small heavily glycosylated glycosylphosphotidylinositol-linked cell surface protein that is expressed in a variety of hematological and solid tumors. It is majorly involved in tumor development, proliferation, invasion, metastasis, and prevention of tumor cell death via various major and minor signalling pathways although it can also inhibit invasiveness via degrading BART mRNA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim and Objective:<\/jats:title>\n                    <jats:p>We aimed to evaluate CD24 expression in gall bladder carcinoma (GBC), via immunohistochemical (IHC) staining on paraffin-embedded histological tissue along with assessment of tumor budding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>\n                      87 patients were enrolled and CD24 IHC staining was evaluated using four degrees of positivity (negative, mild, moderate, and strong). The expression was then correlated with various clinicopathological parameters. Interpretation was tumor budding was done on the H and E slide. Hotspots were chosen and the total number of buds was reported in an area measuring 0.785 mm\n                      <jats:sup>2<\/jats:sup>\n                      corresponding to 20\u00d7 fields in the microscope.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>CD24 positive expression was found in 77.5% of cases. Its positive expression correlated inversely with tumor stage, necrosis, and lymph vascular invasion establishing its usefulness as a prognostic marker. Tumor budding correlated with poor tumor differentiation and higher tumor grade and poorly differentiated cancer with higher budding responded well to chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our study supports the importance of CD24 and tumor budding as prognostic markers and thus its usefulness in risk stratification in GBC. CD 24 positive subgroup of GBC cases may benefit from anti-CD24 mAb therapy and we also recommend that tumor budding may be included in the morphological synoptic reporting in gall bladder cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1986_23","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T20:06:53Z","timestamp":1743710813000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["CD24 and tumor budding as a prognostic variable in carcinoma gall bladder: A pilot study"],"prefix":"10.4103","volume":"21","author":[{"given":"Devanshi Brajesh","family":"Dubey","sequence":"first","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malti Kumar","family":"Maurya","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Bhalla","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Gastroenetrology, AIIMS Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Surgery, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav Arun","family":"Sonkar","sequence":"additional","affiliation":[{"name":"Department of Surgery, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"R1-20250403","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12029-017-0036-5","article-title":"Staging, treatment, and future approaches of gallbladder carcinoma","volume":"49","author":"Shukla","year":"2018","journal-title":"J Gastroint Cancer"},{"key":"R2-20250403","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/ijpm.ijpm_876_21","article-title":"Immunohistochemical appraisal of epithelial mesenchymal transition type III in gall bladder cancer","volume":"66","author":"Yadav","year":"2023","journal-title":"Indian J Pathol Microbiol"},{"key":"R3-20250403","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","article-title":"Epidemiology and molecular pathology of gallbladder cancer","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"R4-20250403","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1007\/s00464-010-0914-4","article-title":"Adequate extent in radical re-resection of incidental gallbladder carcinoma:Analysis of the German Registry","volume":"24","author":"Goetze","year":"2010","journal-title":"Surg Endosc"},{"key":"R5-20250403","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer:ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Valle","year":"2016","journal-title":"Ann Oncol"},{"key":"R6-20250403","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.3390\/cancers12123670","article-title":"Current and new biomarkers for early detection, prognostic stratification, and management of gallbladder cancer patients","volume":"12","author":"Garc\u00eda","year":"2020","journal-title":"Cancers"},{"key":"R7-20250403","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3390\/jcm9092854","article-title":"Molecular profiling in daily clinical practice:Practicalities in advanced cholangiocarcinoma and other biliary tract cancers","volume":"9","author":"Lamarca","year":"2020","journal-title":"J Clin Med"},{"key":"R8-20250403","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1570163814666170818125036","article-title":"Involvement of CD24 in multiple cancer related pathways makes it an interesting new target for cancer therapy","volume":"18","author":"Eyvazi","year":"2018","journal-title":"Curr Cancer Drug Targets"},{"key":"R9-20250403","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10585-011-9426-4","article-title":"CD24 promotes tumor cell invasion by suppressing tissue factorpathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion","volume":"29","author":"Bretz","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"R10-20250403","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/0008-5472.CAN-10-2743","article-title":"Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BPCD24 regulates specific mRNA expression","volume":"71","author":"Taniuchi","year":"2011","journal-title":"Cancer Res"},{"key":"R11-20250403","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/jpm12081235","article-title":"CD24:A novel target for cancer immunotherapy","volume":"12","author":"Panagiotou","year":"2022","journal-title":"J Pers Med"},{"key":"R12-20250403","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/modpathol.2012.94","article-title":"Tumor budding in colorectal carcinoma:Time to take notice","volume":"25","author":"Mitrovic","year":"2012","journal-title":"Modern Pathology"},{"key":"R13-20250403","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC)","volume":"30","author":"Lugli","year":"2016","journal-title":"Mod Pathol"},{"key":"R14-20250403","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-015-3333-3","article-title":"High tumor budding stratifies breast cancer with metastatic properties","volume":"150","author":"Salhia","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R15-20250403","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18632\/oncotarget.199","article-title":"Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer:Tumor budding as oncotarget","volume":"1","author":"Zlobec","year":"2010","journal-title":"Oncotarget"},{"key":"R16-20250403","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s12032-011-0110-y","article-title":"NDRG2 down- regulation and CD24 upregulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma","volume":"29","author":"Song","year":"2012","journal-title":"Med Oncol"},{"key":"R17-20250403","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4103\/0019-509X.197723","article-title":"Place of birth and risk of gallbladder cancer in India","volume":"53","author":"Mhatre","year":"2016","journal-title":"Indian J Cancer"},{"key":"R18-20250403","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00428-020-03012-2","article-title":"Prognostic value of tumor budding in gallbladder cancer:Application of the International Tumor Budding Consensus Conference scoring system","volume":"478","author":"Kim","year":"2021","journal-title":"Virchows Archiv"},{"key":"R19-20250403","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3748\/wjg.v8.i6.1138","article-title":"Expression of MMP-2, TIMP-2 protein and the ratio of MMP-2\/TIMP-2 in gallbladder carcinoma and their significance","volume":"8","author":"Fan","year":"2002","journal-title":"World J Gastroenterol"},{"key":"R20-20250403","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12253-010-9278-2","article-title":"Clinicopathologic and prognostic significance of CD24 in gallbladder carcinoma","volume":"17","author":"Liu","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"R21-20250403","first-page":"815","article-title":"Nicotine inhibits CD24 expression in Lewis lung carcinoma cells by upregulation of RAS expression","volume":"53","author":"Liu","year":"2018","journal-title":"Int J Oncol"},{"key":"R22-20250403","first-page":"EC41","article-title":"Role of epidermal growth factor receptor in gallbladder carcinoma and its association with various clinicopathological parameters:A cross-sectional study","volume":"16","author":"Perme","year":"2022","journal-title":"J Clin Diagn Res"},{"key":"R23-20250403","first-page":"515","article-title":"Tumors of the Liver, Biliary Tree, and Gallbladder","volume":"10","author":"Fletcher","year":"2007","journal-title":"Diagnostic Histopathology of Tumors:Elsevier Health Sciences"},{"key":"R24-20250403","doi-asserted-by":"crossref","first-page":"49156","DOI":"10.18632\/oncotarget.9402","article-title":"Membranous CD24 drives the epithelial phenotype of pancreatic cancer","volume":"7","author":"Lubeseder-Martellato","year":"2016","journal-title":"Oncotarget"},{"key":"R25-20250403","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.suronc.2012.08.002","article-title":"Gallbladder cancer:Past, present and an uncertain future","volume":"21","author":"Boutros","year":"2012","journal-title":"Surg Oncol"},{"key":"R26-20250403","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.humpath.2009.12.016","article-title":"Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract","volume":"41","author":"Rieneret","year":"2010","journal-title":"Hum Pathol"},{"key":"R27-20250403","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s13193-022-01649-w","article-title":"Clinicopathologic correlation of CD44+\/CD24- expression in breast cancer:A report from tertiary care medical university in India","volume":"14","author":"Anand","year":"2023","journal-title":"Indian J Surg Oncol"},{"key":"R28-20250403","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/1947-2714.101979","article-title":"Molecular biology of gallbladder cancer:Potential clinical implications","volume":"4","author":"Andr\u00e9n-Sandberg","year":"2012","journal-title":"N Am J Med Sci"},{"key":"R29-20250403","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12935-019-0911-1","article-title":"Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma","volume":"19","author":"Zhou","year":"2019","journal-title":"Cancer Cell Int"},{"key":"R30-20250403","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1038\/s41598-017-14364-2","article-title":"Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"R31-20250403","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.2147\/CMAR.S198348","article-title":"Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma","volume":"11","author":"Farid","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R32-20250403","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4274\/balkanmedj.galenos.2022.2021-9-37","article-title":"The significance of tumor budding and immunohistochemical Axl expression in gallbladder adenocarcinomas","volume":"39","author":"\u00d6z","year":"2022","journal-title":"Balkan Med J"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1986_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:01:15Z","timestamp":1786647675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1986_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1986_23","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2023-09-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}